SCHEMBL4938482

SCHEMBL4938482

c1cc(N2CCC(NCC3CCCCC3)CC2)ccc1CN1CCOCC1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
KMT2A Q03164 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
KDM4E B2RXH2 1/20 0.49
CXCR3 P49682 1/20 0.48
HRH3 Q9Y5N1 5/20 0.48
L3MBTL3 Q96JM7 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP2D6 P10635 2/20 0.45
HRH1 P35367 2/20 0.45
KCNH2 Q12809 2/20 0.45
CCR5 P51681 1/20 0.42
POLB P06746 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HPGD P15428 1/20 0.41
TPSAB1 Q15661 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4941810 0.86 HRH3 (0.58) NPC1RAB9AKMT2ASMN1; SMN2KDM4E
SCHEMBL4931617 0.85 SMN1; SMN2 (0.58) NPC1RAB9AKMT2ASMN1; SMN2KDM4E
SCHEMBL7847689 0.79 HRH3 (0.53) NPC1RAB9AKMT2ASMN1; SMN2KDM4E
SCHEMBL25769330 0.78 HIF1A (0.56) NPC1RAB9AKMT2ASMN1; SMN2KDM4E
SCHEMBL8186709 0.78 ACHE (0.66) KMT2ACXCR3
SCHEMBL4937224 0.77 HRH3 (0.62) NPC1RAB9AKMT2ASMN1; SMN2HRH3
SCHEMBL23960557 0.77 HIF1A (0.57) NPC1RAB9AKMT2ASMN1; SMN2KDM4E
SCHEMBL3311538 0.76 ACHE (0.68) KMT2ACXCR3
SCHEMBL4940225 0.76 L3MBTL3 (0.81) HRH3L3MBTL3L3MBTL1
SCHEMBL4938456 0.76 HRH3 (0.64) KMT2ASMN1; SMN2KDM4EHRH3L3MBTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556046-A1 PHENYLPIPERIDINES AND PHENYLPYRROLIDINES AS HISTAMINE H3 RECEPTOR MODULATORS Janssen Pharmaceutica N.V. (BE) 2005-07-27 EP claimed
US-20040087573-A1 Phenylpiperidines and phenylpyrrolidines JANSSEN PHARMACEUTICA N.V. (BE) 2004-05-06 US claimed
WO-2004037257-A1 PHENYLPIPERIDINES AND PHENYLPYRROLIDINES AS HISTAMINE H3 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-05-06 WO claimed
US-20080004314-A1 Phenylpiperidines and Phenylpyrrolidines APODACA RICHARD L 2008-01-03 US disclosed
US-7279491-B2 Phenylpiperidines and phenylpyrrolidines JANSSEN PHARMACEUTICA N.V. (BE) 2007-10-09 US disclosed
EP-1556046-A1 PHENYLPIPERIDINES AND PHENYLPYRROLIDINES AS HISTAMINE H3 RECEPTOR MODULATORS Janssen Pharmaceutica N.V. (BE) 2005-07-27 EP disclosed
US-20040087573-A1 Phenylpiperidines and phenylpyrrolidines JANSSEN PHARMACEUTICA N.V. (BE) 2004-05-06 US disclosed
WO-2004037257-A1 PHENYLPIPERIDINES AND PHENYLPYRROLIDINES AS HISTAMINE H3 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087573-A1 Phenylpiperidines and phenylpyrrolidines HRH2, HNMT, HRH3 NPC1 312/4885RAB9A 2357/4885KMT2A 2582/4885
US-20080004314-A1 Phenylpiperidines and Phenylpyrrolidines HRH2, HNMT, HRH3 NPC1 312/4885RAB9A 2357/4885KMT2A 2582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.